Eve review

The phrase this site leads with is worth taking apart, because it is doing two jobs and only one of them honestly. "One hundred percent transparent pricing" sets an expectation of numbers, and what follows is a promise that you are not charged unless a physician approves treatment. That second thing is genuinely good — a consultation that ends in a decline costs nothing, which is not true everywhere — and it is not transparency about price, because no price is ever shown. You can learn precisely when you will be billed and nothing whatsoever about how much. The catalog compounds the impression: four products listed with stock indicators, three of them branded and named, and not a figure against any of them, which reads less like a page that has not got to pricing yet and more like one that has had it taken out. What is done well is the compounding disclosure, which states plainly that a physician may prescribe compounded medication and that the FDA does not review or approve it — that sentence is missing entirely from sites several times this size. For the question this page exists to answer, though, there is nothing to work with: no rate, no dose, no indication whether the branded products are dispensed at cash price or something else.

Vs median

Not comparable — no figure is published before intake

Market

$59–$1300/mo is the full published spread in our ranking

Structure

No low-dose price published

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

Eve does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

The phrase this site leads with is worth taking apart, because it is doing two jobs and only one of them honestly. "One hundred percent transparent pricing" sets an expectation of numbers, and what follows is a promise that you are not charged unless a physician approves treatment. That second thing is genuinely good — a consultation that ends in a decline costs nothing, which is not true everywhere — and it is not transparency about price, because no price is ever shown. A reader can learn precisely when they will be billed and nothing whatsoever about how much. The catalog compounds the impression: four products listed with stock indicators, three of them branded and named, and not a figure against any of them, which reads less like a page that has not got to pricing yet and more like one that has had it taken out. What is done well is the compounding disclosure, which states plainly that a physician may prescribe compounded medication and that the FDA does not review or approve it — that sentence is missing entirely from sites several times this size. For the question this page exists to answer, though, there is nothing to work with: no rate, no dose, no indication whether the branded products are dispensed at cash price or something else.

No price appears anywhere, despite pricing being described as fully transparent.

• None of the four listed products carries a figure of any kind.
• No dose is published, and nothing says what the branded products cost.

Eve is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Is compounded GLP-1 safe?
• The true annual cost of a plan